BEND, Ore.--(BUSINESS WIRE)--
Development of Platform Testing Technologies
EVIO Inc. (“EVIO†or the “Companyâ€), (EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, is pleased to announce that EVIO Canada’s Keystone Labs in Edmonton has received a grant from the German-Canadian Centre for Innovation and Research (GCCIR). The overarching goal of the Alberta-Europe Technology Collaboration Fund is to help participants become more globally competitive by developing innovative technologies and research-based alliances with the potential to foster economic growth.
The grant will allow Keystone Labs to partner with a German company, Mildendo Gesellschaft fur mikrofluidische Systeme mbH, to complete the development of an innovative real-time testing platform. By using real-time testing technology throughout the grow cycle, cultivators can monitor cannabinoid profiles, potency and other important markers of plant development. The technology will also aid with monitoring factors which impact plant health and allow for adjustments throughout the grow cycle.
“We are excited to collaborate with our global partners on this game changing testing technology. Technological advancement in cannabis cultivation will keep Canada at the forefront of the global industry,†stated Jodi McDonald, President of EVIO Canada’s Keystone Labs. “The two-year commitment of the GCCIR grant will take the product from development to commercialization for the global cannabis market.â€
EVIO Canada acquired 50% stake in Keystone Labs in May 2018.
About EVIO Inc.
EVIO Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The Company’s EVIO Labs division operates coast-to-coast providing state-mandated ancillary services to ensure the safety and quality of the nation's cannabis supply. The Company’s EVIO Biosciences Division is dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoid system.
For more information, visit www.eviolabs.com.
About Keystone Labs
Keystone Labs Inc., located in Edmonton, Alberta, is a privately held Heath Canada accredited testing facility with a GMP establishment license. Keystone offers a full array of analytical and microbiological testing services for pharmaceutical, biotechnology, medical device, nutraceutical, medical cannabis and related industries.
For more information, visit https://keystonelabs.ca/.
Safe Harbor Statement
Any statements in this press release that are not statements of historical fact maybe considered to be forward-looking statements. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or www.eviolabs.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181213005194/en/